Cochrane Abstracts
Oxandrolone for growth hormone‐treated girls aged up to 18 years with Turner syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oxandrolone for Growth Hormone‐treated Girls Aged Up to 18 Years With Turner Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433411/all/Oxandrolone_for_growth_hormone‐treated_girls_aged_up_to_18_years_with_Turner_syndrome.
Oxandrolone for growth hormone‐treated girls aged up to 18 years with Turner syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433411/all/Oxandrolone_for_growth_hormone‐treated_girls_aged_up_to_18_years_with_Turner_syndrome. Accessed March 23, 2025.
Oxandrolone for growth hormone‐treated girls aged up to 18 years with Turner syndrome. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433411/all/Oxandrolone_for_growth_hormone‐treated_girls_aged_up_to_18_years_with_Turner_syndrome
Oxandrolone for Growth Hormone‐treated Girls Aged Up to 18 Years With Turner Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433411/all/Oxandrolone_for_growth_hormone‐treated_girls_aged_up_to_18_years_with_Turner_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oxandrolone for growth hormone‐treated girls aged up to 18 years with Turner syndrome
ID - 433411
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433411/all/Oxandrolone_for_growth_hormone‐treated_girls_aged_up_to_18_years_with_Turner_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
